US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Neuroscience and Healthcare ETF

40.00

+0.47041.19%

Volume:536

Turnover:21.45K

Market Cap:8.00M

PE:- -

High:40.04

Open:40.04

Low:40.00

Close:39.53

52wk High:43.01

52wk Low:24.78

Shares:200.00K

Float Shares:200.00K

Volume Ratio:0.68

T/O Rate:0.27%

Dividend:0.32

Dividend Rate:0.80%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Policy Boost for Assistive Devices and Brain-Computer Interface Sector as 14 Ministries Issue Joint Action Plan

Dianthus Therapeutics EVP, CFO and CBO Ryan Savitz Disposes of Common Shares Worth $3.06 Million

Analysts Conflicted on These Healthcare Names: Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Medicines (PRAX)

Alkermes Plc : TD Cowen Raises Target Price to $57 from $50

THOMSON REUTERS

Analysts Are Bullish on Top Healthcare Stocks: Praxis Precision Medicines (PRAX), Sino Biopharmaceutical (SBMFF)

Alkermes Price Target Announced at $60.00/share by JP Morgan

Alkermes Says Alixorexton Sustains Wakefulness Gains in Nine-month Narcolepsy Extension Study Interim Analysis

Alkermes - Alixorexton Generally Well Tolerated at All Doses Tested

THOMSON REUTERS

Alkermes - Alixorexton Shows Sustained Improvement on Mwt and ESS at Week 24, Nine Months After First Dose

THOMSON REUTERS

Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults with Narcolepsy Type 1 and Type 2 in Long-term Extension Study Interim Analysis

THOMSON REUTERS

Praxis Precision Med Initiated at Buy by Goldman Sachs

Praxis Precision initiated with a Buy at Goldman Sachs

Bank of America Securities Remains a Sell on Alkermes (ALKS)

Wanlian Securities Forecasts Revaluation for Domestic Innovative Drugs, Highlights Emerging Tech Like Brain-Computer Interfaces

Alkermes Plc : JP Morgan Resumes Coverage with Neutral Rating; Target Price $60

THOMSON REUTERS

Scholar Rock Holding (SRRK) Rallies As Pipeline Story Meets A Fair Value Question

Simply Wall St.

RBC Capital Remains a Buy on Praxis Precision Medicines (PRAX)

Can Praxis Precision Medicines (PRAX) Merit A Higher Valuation As It Expands Ulixacaltamide Delivery?

Simply Wall St.

Praxis Precision Medicines Seen Having Greater Commercial Upside for Relutrigine, RBC Says

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Immunome (IMNM)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/IBRN/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","market":"US","secType":"STK","nameCN":"iShares Neuroscience and Healthcare ETF","latestPrice":40.0001,"timestamp":1787675820682,"preClose":39.5297,"halted":0,"volume":536,"delay":0,"changeRate":0.011899913229799493,"floatShares":200000,"shares":200000,"eps":0,"marketStatus":"Trading","change":0.4704,"latestTime":"08-25 12:42:08 EDT","open":40.04,"high":40.04,"low":40.0001,"amount":21447.827208,"amplitude":0.001009,"askPrice":40.19,"askSize":300,"bidPrice":39.91,"bidSize":300,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":39.5297,"sharesOutstanding":150000,"nav":39.601587,"aum":7920317.4,"dividendRate":0.008027,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":39.45,"preClose":39.5297,"latestTime":"16:10 EDT","volume":6,"amount":237.1782,"timestamp":1787602204712,"change":-0.0797,"changeRate":-0.002016,"amplitude":0},"volumeRatio":0.681973,"impliedVol":0.1031,"impliedVolPercentile":0.6096},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","floatShares":200000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.681973,"shares":200000,"dividePrice":0.3211,"high":40.04,"amplitude":0.001009,"preClose":39.5297,"low":40.0001,"week52Low":24.78,"pbRate":"--","week52High":43.01,"institutionHeld":0,"latestPrice":40.0001,"eps":0,"divideRate":0.008027,"volume":536,"delay":0,"ttmEps":0,"open":40.04,"prevYearClose":32.3193,"prevWeekClose":39.6482,"prevMonthClose":36.6044,"prevQuarterClose":38.8263,"fiveDayClose":39.7665,"twentyDayClose":37.4412,"sixtyDayClose":35.6957},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBRN\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"IBRN","amount":0.319807,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2024-12-17","symbol":"IBRN","amount":0.10114,"announcedDate":"2024-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2023-12-20","symbol":"IBRN","amount":0.006303,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"},{"date":"2023-06-07","symbol":"IBRN","amount":0.008241,"announcedDate":"2023-05-12","type":"dividend","market":"US","newRecordDate":"2023-06-08","defaultRemindTime":1686144600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-06-13","payableDate":"2023-06-08","currency":"USD","dateTimestamp":1686110400000,"payDate":"2023-06-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBRN\",market:\"US\",,,undefined,":[{"executeDate":"2023-06-07","recordDate":"2023-06-08","paymentDate":"2023-06-13","value":0.008241,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.006303,"currency":"USD"},{"executeDate":"2024-12-17","recordDate":"2024-12-17","paymentDate":"2024-12-20","value":0.10114,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-19","value":0.319807,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBRN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBRN\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1191857286","title":"Policy Boost for Assistive Devices and Brain-Computer Interface Sector as 14 Ministries Issue Joint Action Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1191857286","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191857286?lang=en_us&edition=fundamental","pubTime":"2026-07-14 07:16","pubTimestamp":1783984611,"startTime":"0","endTime":"0","summary":"Multiple government ministries have jointly issued a three-year action plan to expand and enhance the rehabilitation assistive devices industry, providing policy support for related technologies...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1170","BK1100","KCAI","BK1574","BK4588","06609","IBRN","06613","BK1587","02172","BK4585","MNTL","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651485144","title":"Dianthus Therapeutics EVP, CFO and CBO Ryan Savitz Disposes of Common Shares Worth $3.06 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2651485144","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651485144?lang=en_us&edition=fundamental","pubTime":"2026-07-14 05:00","pubTimestamp":1783976450,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics EVP, CFO and CBO Ryan Savitz disposes of common shares worth $3.06 millionDianthus Therapeutics EVP, CFO and CBO Ryan Savitz exercised stock options for 31,249 common shares at $","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL8JR9Kj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Dianthus Therapeutics EVP, CFO and CBO Ryan Savitz Disposes of Common Shares Worth $3.06 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","IBRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651143954","title":"Analysts Conflicted on These Healthcare Names: Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Medicines (PRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651143954","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651143954?lang=en_us&edition=fundamental","pubTime":"2026-07-14 00:10","pubTimestamp":1783959019,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Me...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alkermes-alks-transmedics-group-tmdx-and-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alkermes-alks-transmedics-group-tmdx-and-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU2065731478.USD","MEDX","XBI","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU0889565916.HKD","IE0002141913.USD","BK4581","LU0029874061.USD","IE00B4R5TH58.HKD","BK4082","IBRN","HCSG","ALKS","FBT","LU0109394709.USD","BK4137","BK4585","PSIL","IE00B2B36J28.USD","LU0320765992.SGD","BK4139","LU2324357040.USD","LU0128526141.USD","PRAX","IE00BJT1NW94.SGD","XLV","TMDX","PSCH","BK4588","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651128211","title":"Alkermes Plc : TD Cowen Raises Target Price to $57 from $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2651128211","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651128211?lang=en_us&edition=fundamental","pubTime":"2026-07-13 21:29","pubTimestamp":1783949398,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43F0V4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PSIL","MEDX","ALKS","IBRN","PSCH","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651111442","title":"Analysts Are Bullish on Top Healthcare Stocks: Praxis Precision Medicines (PRAX), Sino Biopharmaceutical (SBMFF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651111442","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651111442?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:40","pubTimestamp":1783946410,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Praxis Precision Medicines (PRAX), Sino Biopharmaceu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-praxis-precision-medicines-prax-sino-biopharmaceutical-sbmff-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-praxis-precision-medicines-prax-sino-biopharmaceutical-sbmff-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","IE00BJT1NW94.SGD","IE0002141913.USD","IE0009355771.USD","PRAX","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4139","IE00B4R5TH58.HKD","SBMFF","LU0320765992.SGD","IE00BFTCPJ56.SGD","IBRN","BK4007","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651115701","title":"Alkermes Price Target Announced at $60.00/share by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2651115701","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651115701?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:10","pubTimestamp":1783941000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALKS/analyst-ratings(END) Dow Jones NewswiresJuly 13, 2026 07:10 ET","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","BK4139","IBRN","MEDX","FBT","PSIL","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651115250","title":"Alkermes Says Alixorexton Sustains Wakefulness Gains in Nine-month Narcolepsy Extension Study Interim Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2651115250","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651115250?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:01","pubTimestamp":1783940468,"startTime":"0","endTime":"0","summary":"Alkermes says alixorexton sustains wakefulness gains in nine-month narcolepsy extension study interim analysisAlkermes reported interim long-term extension results showing alixorexton sustained clinic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL7r2w61:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","BK4139","IBRN","FBT","PSCH","ALKS","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651904115","title":"Alkermes - Alixorexton Generally Well Tolerated at All Doses Tested","url":"https://stock-news.laohu8.com/highlight/detail?id=2651904115","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651904115?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:00","pubTimestamp":1783940428,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43D02G:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALKS","MEDX","IBRN","BK4139","PSIL","PSCH","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651115976","title":"Alkermes - Alixorexton Shows Sustained Improvement on Mwt and ESS at Week 24, Nine Months After First Dose","url":"https://stock-news.laohu8.com/highlight/detail?id=2651115976","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651115976?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:00","pubTimestamp":1783940428,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43D02G:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","PSIL","ALKS","FBT","IBRN","PSCH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651115189","title":"Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults with Narcolepsy Type 1 and Type 2 in Long-term Extension Study Interim Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2651115189","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651115189?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:00","pubTimestamp":1783940428,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43D02G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","BK4139","IBRN","FBT","PSCH","ALKS","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651793190","title":"Praxis Precision Med Initiated at Buy by Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2651793190","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651793190?lang=en_us&edition=fundamental","pubTime":"2026-07-13 17:52","pubTimestamp":1783936320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRAX/analyst-ratings(END) Dow Jones NewswiresJuly 13, 2026 05:52 ET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE0004086264.USD","BK4516","LU0868494708.USD","BK4139","LU0096364046.USD","IE00B2B36J28.USD","LU1668664300.SGD","LU2237438978.USD","LU2471134952.CNY","IBRN","LU1868836591.USD","LU0868494617.USD","LU1868837136.USD","IE0004091025.USD","IE0009355771.USD","IE00BSNM7G36.USD","IE00BFXG1179.USD","LU2237443382.USD","LU0109394709.USD","IE00B19Z3581.USD","IE00BJT1NW94.SGD","LU0251131958.USD","LU2237443465.HKD","LU2237443549.SGD","LU2471134879.HKD","LU0889565916.HKD","BK4533","IE0002270589.USD","LU0742534661.SGD","LU1868836757.USD","LU0320765992.SGD","GSX","LU1868836914.USD","LU2471134523.USD","BK4552","LU1894683264.USD","IE00B19Z3B42.SGD","BK4127","BK4585","LU2265009873.SGD","LU0251142724.SGD","LU2237443622.USD","IE00BFTCPJ56.SGD","LU1791807156.HKD","LU2471134796.USD","LU0061475181.USD","BK4504","PRAX","IE0034235188.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651190997","title":"Praxis Precision initiated with a Buy at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2651190997","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651190997?lang=en_us&edition=fundamental","pubTime":"2026-07-13 17:25","pubTimestamp":1783934704,"startTime":"0","endTime":"0","summary":"Goldman Sachs initiated coverage of Praxis Precision (PRAX) with a Buy rating and $447 price target Praxis is a clinical-stage biotech company with...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/praxis-precision-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/praxis-precision-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BSNM7G36.USD","LU2237443465.HKD","BK4533","LU0048573561.USD","IE0002141913.USD","LU0345770993.USD","LU1868836591.USD","LU0106831901.USD","IE00BJJMRZ35.SGD","BBC","LU0742534661.SGD","LU2237443549.SGD","LU0889565916.HKD","LU2750360641.GBP","IBRN","LU1894683348.USD","LU2237438978.USD","LU2471134796.USD","LU2750360997.AUD","LU0942090050.USD","LU0061475181.USD","IE0004086264.USD","IE0004091025.USD","LU0868494708.USD","GSX","LU1804176565.USD","IE0034235188.USD","IE00B2B36J28.USD","LU2237443622.USD","LU2471134523.USD","LU2237443382.USD","BK4552","IE00BFTCPJ56.SGD","BK4516","BK4504","IE0009355771.USD","LU1868836914.USD","LU1894683264.USD","BK4588","IE00B4R5TH58.HKD","LU1868837136.USD","IE00BJT1NW94.SGD","IE00BFXG1179.USD","LU1791807156.HKD","BK4127","BK4139","PRAX","LU0345770308.USD","IE00B19Z3B42.SGD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651192046","title":"Bank of America Securities Remains a Sell on Alkermes (ALKS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651192046","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651192046?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:45","pubTimestamp":1783932314,"startTime":"0","endTime":"0","summary":"In a report released on July 10, Jason Gerberry from Bank of America Securities maintained a Sell rating on Alkermes, with a price target of $38.00...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-sell-on-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-sell-on-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IYF","LU1506573853.SGD","IE00B19Z3581.USD","BK4207","LU0648000940.SGD","IE00BLSP4452.SGD","ALKS","FBT","VFH","MEDX","XLF","LU0306807586.USD","LU0130102774.USD","IE00BZ1G4Q59.USD","LU0640476718.USD","IBRN","LU0306806265.USD","LU2129689514.USD","UYG","LU1894683348.USD","PSIL","FTXO","KBWB","LU0320765489.SGD","LU0868494617.USD","LU2133065610.SGD","FNCL","BK4559","PGF","LU0321505439.SGD","LU0106831901.USD","LU1718418525.SGD","LU1894683264.USD","BAC","LU0208291251.USD","LU0130518102.USD","LU0070302665.USD","BK4581","LU0256863902.USD","PSCH","IYG","LU2265009873.SGD","LU0417517546.SGD","LU0234572021.USD","LU0203347892.USD","LU1201861249.SGD","LU0211331839.USD","LU0648001328.SGD","LU1363072403.SGD","LU0980610538.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195001515","title":"Wanlian Securities Forecasts Revaluation for Domestic Innovative Drugs, Highlights Emerging Tech Like Brain-Computer Interfaces","url":"https://stock-news.laohu8.com/highlight/detail?id=1195001515","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195001515?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:25","pubTimestamp":1783931117,"startTime":"0","endTime":"0","summary":"China's pharmaceutical sector has seen a significant pullback in its overall valuation from previous highs and is currently positioned at a historical median level. Broadly, the pharmaceutical...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161027","MEDX","IBRN","159992","IBBQ","BK1574","06978","BK1161","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651193713","title":"Alkermes Plc : JP Morgan Resumes Coverage with Neutral Rating; Target Price $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2651193713","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651193713?lang=en_us&edition=fundamental","pubTime":"2026-07-13 13:58","pubTimestamp":1783922324,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43F04A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALKS","PSCH","PSIL","BK4139","MEDX","IBRN","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650816812","title":"Scholar Rock Holding (SRRK) Rallies As Pipeline Story Meets A Fair Value Question","url":"https://stock-news.laohu8.com/highlight/detail?id=2650816812","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650816812?lang=en_us&edition=fundamental","pubTime":"2026-07-12 14:25","pubTimestamp":1783837501,"startTime":"0","endTime":"0","summary":"Scholar Rock Holding (SRRK) has drawn fresh attention after recent share price moves, prompting investors to revisit how its clinical-stage pipeline and current financial profile line up with expectations in the neuromuscular disease space.\nSee our latest analysis for Scholar Rock Holding.\nAt a latest share price of US$56.71, Scholar Rock Holding has given investors a 30 day share price return of 28.36% and a year to date share price return of 32.50%. The 1 year total shareholder return of...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srrk/scholar-rock-holding/news/scholar-rock-holding-srrk-rallies-as-pipeline-story-meets-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srrk/scholar-rock-holding/news/scholar-rock-holding-srrk-rallies-as-pipeline-story-meets-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["THNR","SRRK","IBRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650539921","title":"RBC Capital Remains a Buy on Praxis Precision Medicines (PRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650539921","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650539921?lang=en_us&edition=fundamental","pubTime":"2026-07-11 09:47","pubTimestamp":1783734474,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Leonid Timashev maintained a Buy rating on Praxis Precision Medicines yesterday and set a price target of $449.00. According to...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJT1NW94.SGD","LU0128525929.USD","IE00B4R5TH58.HKD","IE0002141913.USD","LU0109394709.USD","GSIB","LU1267930573.SGD","IE00B2B36J28.USD","BK4207","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","BK4139","IBRN","IE0009355771.USD","PRAX","LU0320765992.SGD","LU0310800379.SGD","LU0889565916.HKD","LU0708994859.HKD","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650133950","title":"Can Praxis Precision Medicines (PRAX) Merit A Higher Valuation As It Expands Ulixacaltamide Delivery?","url":"https://stock-news.laohu8.com/highlight/detail?id=2650133950","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650133950?lang=en_us&edition=fundamental","pubTime":"2026-07-10 20:29","pubTimestamp":1783686555,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines (PRAX) has entered into a research collaboration and license agreement with Remagine Labs to develop an iontophoretic transdermal patch for ulixacaltamide, extending its essential tremor program beyond the existing oral approach.\nSee our latest analysis for Praxis Precision Medicines.\nThe collaboration news lands after a strong run in Praxis Precision Medicines' share price, with a 30 day share price return of 33.07% and year to date share price return of 16.31%,...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prax/praxis-precision-medicines/news/can-praxis-precision-medicines-prax-merit-a-higher-valuation","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prax/praxis-precision-medicines/news/can-praxis-precision-medicines-prax-merit-a-higher-valuation","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE0009355771.USD","IE0002141913.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0889565916.HKD","PRAX","IBRN","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","BK4139","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650803221","title":"Praxis Precision Medicines Seen Having Greater Commercial Upside for Relutrigine, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2650803221","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650803221?lang=en_us&edition=fundamental","pubTime":"2026-07-10 20:18","pubTimestamp":1783685933,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines  could see greater commercial upside from its relutrigine epilepsy program as the rare epilepsy market may support premium pricing for the therapy, RBC Capital Markets said in a Friday note.The firm said discussions with management and a review of existing developmental and epileptic encephalopathy therapies suggest relutrigine could sustain a list price of about $450,000 to $650,000.RBC said the higher price could result in stricter payer requirements and initially limit use to patients with more severe disease. Even so, the firm now projects relutrigine revenue of about $2.6 billion by 2035, above the consensus estimate of about $2.45 billion.The firm also said management has not yet decided the path forward for vormatrigine following the recent POWER1 setback, although it continues to evaluate the program.RBC maintained its outperform rating on Praxis Precision Medicines and its $449 price target.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0109394709.USD","LU0889565916.HKD","IBRN","IE0002141913.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4139","IE0009355771.USD","PRAX","LU0320765992.SGD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650292217","title":"Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Immunome (IMNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650292217","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650292217?lang=en_us&edition=fundamental","pubTime":"2026-07-09 21:10","pubTimestamp":1783602606,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS) and Immunome (IMNM) with bullish sen...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4588","BK4581","ALKS","HCSG","PSIL","BK4585","IMNM","LU0128526141.USD","LU0029874061.USD","BK4139","FBT","LABU","XLV","IBRN","BK4563","PSCH","MEDX","BK4137"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}